Retrieved 14 May 2022, from A Phase III, randomized, double blind, placebo controlled, parallel group study, to evaluate the safety and efficacy of subcutaneous implants of afamelanotide (16 mg) in patients suffering from polymorphic light eruption (PLE)
8,9 Spurred by recent approvals, the obesity market is expected to be worth over $100 billion by the end of the decade, up from $2.8 billion in 2022
The most active catechin, EGCG (epigallocatechin gallate), works synergistically with caffeine
In addition, the application of exendin-4, a GLP-1RA in obese mice triggered by diet restores C1q/TNF-related protein 3 (CTRP3) expression in keratinocytes, thereby inhibiting STAT3 phosphorylation via lysosomal-associated membrane protein 1 (LAMP1) and alleviating the psoriatic symptoms induced by imiquimod treatment [204]
Of course, not every medication works for everyone in the same way